1772P Characterisation of a DNA repair deficiency (DRD) biomarker phenotype in metastatic urothelial carcinoma (mUC) within the ATLANTIS clinical trial platform (Q115221980)
Jump to navigation
Jump to search
scientific article published in 2022
Language | Label | Description | Also known as |
---|---|---|---|
English | 1772P Characterisation of a DNA repair deficiency (DRD) biomarker phenotype in metastatic urothelial carcinoma (mUC) within the ATLANTIS clinical trial platform |
scientific article published in 2022 |
Statements
1772P Characterisation of a DNA repair deficiency (DRD) biomarker phenotype in metastatic urothelial carcinoma (mUC) within the ATLANTIS clinical trial platform (English)
S.J. Crabb
L. Dempsey
E. Soulis
S. Hinsley
Y.P. Song
J. Barber
J. Frew
J. Gale
G. Faust
S. Brock
U.B. McGovern
O.A. Parikh
D. Enting
S. Sundar
G. Ratnayake
K. Lees
S.A. Hussain
T.B. Powles
R. Jones
W. Tapper
September 2022
33
S1348